Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomasCem Demirkiran, Alessandro D. Santin|Gynecologic Oncology|2024Cited by 8
Preclinical Efficacy of the Estrogen Receptor Degrader Fulvestrant in Combination with RAF/MEK Clamp Avutometinib and FAK Inhibitor in a Low-Grade Serous Ovarian Cancer Animal Model with Acquired Resistance to Chemotherapy and Aromatase InhibitorCem Demirkiran, Alessandro D. Santin|International Journal of Molecular Sciences|2025Cited by 2